- Home
- ATXS vs SATL Comparison
ATXS vs SATL Comparison
Compare ATXS & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- SATL
- Stock Information
- Founded
- ATXS 2008
- SATL 2010
- Country
- ATXS United States
- SATL United States
- Employees
- ATXS N/A
- SATL N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- ATXS Health Care
- SATL Technology
- Exchange
- ATXS Nasdaq
- SATL Nasdaq
- Market Cap
- ATXS 401.2M
- SATL 433.8M
- IPO Year
- ATXS 2015
- SATL N/A
- Fundamental
- Price
- ATXS $6.65
- SATL $3.56
- Analyst Decision
- ATXS Strong Buy
- SATL
- Analyst Count
- ATXS 7
- SATL 0
- Target Price
- ATXS $32.43
- SATL N/A
- AVG Volume (30 Days)
- ATXS 304.1K
- SATL 1.7M
- Earning Date
- ATXS 08-11-2025
- SATL 08-14-2025
- Dividend Yield
- ATXS N/A
- SATL N/A
- EPS Growth
- ATXS N/A
- SATL N/A
- EPS
- ATXS N/A
- SATL N/A
- Revenue
- ATXS N/A
- SATL $12,929,000.00
- Revenue This Year
- ATXS N/A
- SATL N/A
- Revenue Next Year
- ATXS N/A
- SATL N/A
- P/E Ratio
- ATXS N/A
- SATL N/A
- Revenue Growth
- ATXS N/A
- SATL 9.47
- 52 Week Low
- ATXS $3.56
- SATL $0.72
- 52 Week High
- ATXS $12.92
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- ATXS 60.88
- SATL 50.65
- Support Level
- ATXS $5.94
- SATL $3.39
- Resistance Level
- ATXS $6.49
- SATL $3.77
- Average True Range (ATR)
- ATXS 0.34
- SATL 0.22
- MACD
- ATXS -0.00
- SATL 0.02
- Stochastic Oscillator
- ATXS 74.74
- SATL 50.00
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.